Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications approved by the FDA for treating type 2 diabetes and, in some formulations, for chronic weight management
Compounded versions often use unauthorized ingredients, such as salt forms of semaglutide, or exceed approved dosage guidelines, further increasing risks
Can you tell us about your weight loss journey, before GLP-1
Some participants in GLP-1 weight loss programs have experienced more severe side effects, though they are less common
This makes them suitable for a proof-of-concept trial: there is real variation to detect, and a real-world population that would benefit from better intervention options
If Glutathione is taken by people suffering from asthma, it can lead to wheezing